safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease
Published 1 year ago • 1.7K plays • Length 11:52Download video MP4
Download video MP3
Similar videos
-
2:58
diabetic kidney disease, animation
-
3:41
jennifer green, easd 2022: finerenone & empagliflozin in patients with ckd and t2d: confidence study
-
2:10
the new chronic kidney disease medicine and treatment option approved | empagliflozin
-
3:38
evaluation of efpeglenatide on cardiovascular and renal outcomes in patients with type 2 diabetes
-
6:07
farxiga, jardiance or invokana users: know this!
-
13:59
understanding chronic kidney disease (ckd)
-
4:22
farxiga fda approved kidney disease treatment. should you use it or not? *shocking research*
-
3:21
empa ckd - 3 min trial summary
-
9:59
recovery trial - empagliflozin
-
8:40
chronic kidney disease - causes, symptoms, diagnosis, treatment, pathology
-
2:54
know your risk, empower your health | important strategies to prevent & manage diabetes
-
9:06
sglt2 inhibitors in chronic kidney disease
-
3:06
empagliflozin: a game changer for chronic kidney disease
-
19:55
improving renal outcomes with glucose-lowering therapy in the individualized management of t2dm
-
2:41
fda approves empagliflozin for reducing kidney disease progression in ckd patients
-
6:30
chronic kidney disease (ckd): what you need to be wary of | dr francisco (nephrologist)
-
57:22
emerging data from empa-kidney study
-
3:53
diabetes care in renal disease: clinical considerations
-
3:00
managing diabetic kidney disease: what to know before you refer
-
2:40
a diabetes drug might also save patients with acute kidney injury
-
18:37
empagliflozin for diabetes , or heart failure , or also kidney failure.
-
2:19
empagliflozin | medicine information